5 Things You Should Know About Prostate Cancer Clinical Trials

0
(0)

prostate_5

1. There Are Many Benefits From Participating in a Trial

Clinical trials are extremely important scientific studies. The investigation of new medical treatments for diseases like prostate cancer needs clinical trials, which are required by the the U.S. Food and Drug Administration (FDA) to assess new medical treatments. The benefits are shared by investigators and patients, who gain access to new treatments, to expert medical care, to free treatment or reduced costs, and who hep advance science and, therefore, other patients.

Read more about the possible pros and cons of clinical trial participation here.

2. Ask Questions Before Accepting to Participate in a Trial

Regardless of the benefits, it is normal for prostate cancer patients to feel insecure about participating in a clinical trial. Therefore, it is important for them to ask all the right questions, which should be answered before enrolling in any clinical trial. There are some key questions about the trial itself and about the treatment, but patients should feel free to ask study coordinators any additional questions they may have, to ensure their concerns are well-addressed before the trial starts.

Read about key questions to ask before participating in a prostate cancer clinical trial here.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • NCCN and Rubraca
  • Orgovyx and FDA approval
  • Lynparza
  • Erleada results

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

One comment

  1. Brian Haselum says:

    I am currently receiving treatment for early metastatic prostate cancer. The treatment resulting from two recent trials, one in the USA Chaarted and one in the U.K. Stampede, using both Docetaxel and Goselerin . I am now halfway through the Chemotherapy 6 doses every three weeks and the first injection of Goselerin 4 weeks ago. I had a PSA test yesterday hopefully results are good

Leave a Comment

Your email address will not be published. Required fields are marked *